Your browser is no longer supported. Please, upgrade your browser.
Settings
IBIO iBio, Inc. daily Stock Chart
IBIO [NYSE]
iBio, Inc.
Index- P/E- EPS (ttm)-0.17 Insider Own50.48% Shs Outstand121.33M Perf Week1.83%
Market Cap19.53M Forward P/E- EPS next Y- Insider Trans24.36% Shs Float46.55M Perf Month-42.70%
Income-15.50M PEG- EPS next Q- Inst Own2.70% Short Float0.67% Perf Quarter-48.06%
Sales0.40M P/S48.84 EPS this Y-36.10% Inst Trans5.17% Short Ratio0.36 Perf Half Y-56.47%
Book/sh0.10 P/B1.61 EPS next Y- ROA-30.50% Target Price3.00 Perf Year-60.73%
Cash/sh0.07 P/C2.41 EPS next 5Y- ROE-155.70% 52W Range0.14 - 0.56 Perf YTD-59.24%
Dividend- P/FCF- EPS past 5Y-2.70% ROI-41.70% 52W High-70.87% Beta0.74
Dividend %- Quick Ratio4.20 Sales past 5Y-21.00% Gross Margin- 52W Low16.42% ATR0.02
Employees7 Current Ratio4.30 Sales Q/Q-66.70% Oper. Margin- RSI (14)31.87 Volatility15.30% 10.17%
OptionableNo Debt/Eq2.84 EPS Q/Q-62.20% Profit Margin- Rel Volume1.32 Prev Close0.16
ShortableYes LT Debt/Eq2.82 EarningsNov 24 BMO Payout- Avg Volume865.89K Price0.16
Recom- SMA20-25.12% SMA50-40.46% SMA200-52.84% Volume437,076 Change1.30%
Dec-08-17 02:53PM  iBio Inc (IBIO): Does -31.1% EPS Decline Lately Make It An Underperformer? Simply Wall St.
01:03PM  ETFs with exposure to iBio, Inc. : December 8, 2017 Capital Cube
Nov-30-17 04:15PM  iBio, Inc. Closes $4,500,000 Offering of Common Stock GlobeNewswire
Nov-29-17 09:00AM  iBio, Inc. Prices $4,500,000 Firm Commitment Offering of Common Stock GlobeNewswire -31.61%
Nov-28-17 05:07PM  iBio, Inc. Announces Proposed Public Offering of Common Stock GlobeNewswire
Nov-27-17 02:12PM  ETFs with exposure to iBio, Inc. : November 27, 2017 Capital Cube
Nov-14-17 02:27PM  ETFs with exposure to iBio, Inc. : November 14, 2017 Capital Cube
Nov-13-17 09:20AM  iBio, Inc. :IBIO-US: Earnings Analysis: Q1, 2018 By the Numbers : November 13, 2017 Capital Cube
Nov-08-17 12:00PM  AEMD: Upcoming FDA Meeting Expected to Define U.S. Regulatory Pathway Zacks Small Cap Research
Nov-06-17 05:00PM  iBio, Inc. Initiates Litigation Against Fraunhofer-Gesellschaft in Delaware Chancery Court GlobeNewswire
Oct-30-17 08:30AM  iBio CDMO President to Co-Chair South African Molecular Pharming Conference GlobeNewswire
Oct-24-17 09:39AM  ETFs with exposure to iBio, Inc. : October 24, 2017 Capital Cube -5.51%
Oct-23-17 08:00AM  IBio, Aethlon Agreement, The Biologics Market, and Analysts Target, CFB-03 Update ACCESSWIRE
Oct-18-17 07:00AM  Featured Company News - iBio Announces Large-Scale Manufacturing Collaboration with Aethlon Medical ACCESSWIRE
Oct-16-17 07:15AM  iBio Announces Manufacturing Collaboration with Aethlon Medical GlobeNewswire
07:15AM  Aethlon Medical Announces Large-Scale Production Collaboration PR Newswire
Oct-13-17 10:56AM  ETFs with exposure to iBio, Inc. : October 13, 2017 Capital Cube
Oct-05-17 05:36PM  What Are The Drivers Of iBio Incs (IBIO) Risks? Simply Wall St.
Oct-04-17 09:00AM  iBio, Inc. :IBIO-US: Earnings Analysis: Q4, 2017 By the Numbers : October 4, 2017 Capital Cube
Oct-02-17 10:54AM  ETFs with exposure to iBio, Inc. : October 2, 2017 Capital Cube
08:30AM  iBio Appoints James Abbey, Ph.D. as Vice President of Strategic Business Development GlobeNewswire
Sep-20-17 05:40PM  ETFs with exposure to iBio, Inc. : September 20, 2017 Capital Cube +18.81%
08:00AM  iBio, Inc. Intellectual Property Update GlobeNewswire
Sep-19-17 05:55PM  iBio Makes NYSE MKT Section 610(b) Public Announcement GlobeNewswire -11.35%
02:27PM  iBio, Inc. :IBIO-US: Earnings Analysis: 2017 By the Numbers : September 19, 2017 Capital Cube
Sep-18-17 08:00AM  iBio and TheoremDx Collaborate to Develop Proteins for Rapid Diagnostics Testing Products GlobeNewswire +22.84%
Jul-25-17 07:12AM  AzarGen Biotechnologies Granted European Patent for Plant-Made PRODUCTION OF RECOMBINANT HUMAN SURFACTANT PROTEIN-B PR Newswire +24.24%
Jul-24-17 08:30AM  iBio, Inc. Enters into Common Stock Purchase Agreement for Up to $16.0 Million with Lincoln Park Capital GlobeNewswire -13.55%
Jul-12-17 01:00PM  Wednesdays Biotech Movers: Ibio Inc (IBIO) Rallies, Ocular Therapeutix Inc (OCUL) Tumbles, Alder Biopharmaceuticals Inc (ALDR) Dives SmarterAnalyst +13.57%
08:32AM  US Patent Granted to AzarGen Biotechnologies for Synthetic Promoter Technology PR Newswire
Jul-10-17 02:38PM  ETFs with exposure to iBio, Inc. : July 10, 2017 Capital Cube
Jun-05-17 02:21PM  ETFs with exposure to iBio, Inc. : June 5, 2017 Capital Cube +9.06%
08:30AM  iBio, Inc. to Present Plant-Made Pharmaceutical Platform at Plant-Based Vaccines, Antibodies & Biologics Conference GlobeNewswire
May-25-17 12:41PM  ETFs with exposure to iBio, Inc. : May 25, 2017 Capital Cube
May-24-17 10:27AM  iBio, Inc. :IBIO-US: Earnings Analysis: Q3, 2017 By the Numbers : May 24, 2017 Capital Cube
May-04-17 04:01PM  iBio, Inc. Provides Corporate Update at Annual Shareholders Meeting Marketwired
Apr-25-17 03:36PM  ETFs with exposure to iBio, Inc. : April 25, 2017 Capital Cube
Apr-07-17 04:50PM  ETFs with exposure to iBio, Inc. : April 7, 2017 Capital Cube
Mar-27-17 03:59PM  ETFs with exposure to iBio, Inc. : March 27, 2017 Capital Cube
03:59PM  ETFs with exposure to iBio, Inc. : March 27, 2017
Mar-20-17 12:08PM  iBio, Inc. :IBIO-US: Earnings Analysis: Q2, 2017 By the Numbers : March 20, 2017 Capital Cube
12:08PM  iBio, Inc. :IBIO-US: Earnings Analysis: Q2, 2017 By the Numbers : March 20, 2017
Mar-06-17 05:01PM  IBIO, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
Feb-25-17 01:04PM  IBIO, INC. Financials
Feb-24-17 05:04PM  IBIO, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Ma
Feb-21-17 04:06PM  IBIO, INC. Files SEC form 10-Q, Quarterly Report
Jan-27-17 08:30AM  Court Schedules Hearing To Consider Approval Of Settlement Of Derivative Action Marketwired
Jan-25-17 01:18PM  ETFs with exposure to iBio, Inc. : January 25, 2017 Capital Cube +5.21%
01:18PM  ETFs with exposure to iBio, Inc. : January 25, 2017
Jan-04-17 11:06AM  ETFs with exposure to iBio, Inc. : January 4, 2017 +16.18%
Dec-21-16 12:26PM  ETFs with exposure to iBio, Inc. : December 21, 2016 Capital Cube -7.50%
12:26PM  ETFs with exposure to iBio, Inc. : December 21, 2016
Dec-09-16 12:19PM  ETFs with exposure to iBio, Inc. : December 9, 2016 Capital Cube
12:19PM  ETFs with exposure to iBio, Inc. : December 9, 2016
Dec-08-16 08:14AM  iBio, Inc. :IBIO-US: Earnings Analysis: Q1, 2017 By the Numbers : December 8, 2016 Capital Cube
08:14AM  iBio, Inc. :IBIO-US: Earnings Analysis: Q1, 2017 By the Numbers : December 8, 2016
Nov-21-16 08:31AM  Another iBio Plague Vaccine Patent Issues Marketwired -5.86%
Nov-18-16 05:06PM  IBIO, INC. Files SEC form 10-Q, Quarterly Report
Nov-10-16 08:31AM  iBio Expands Product Development Capacity of cGMP Plant Marketwired
Nov-07-16 12:32PM  ETFs with exposure to iBio, Inc. : November 7, 2016 Capital Cube
12:32PM  ETFs with exposure to iBio, Inc. : November 7, 2016
Oct-25-16 02:48PM  ETFs with exposure to iBio, Inc. : October 25, 2016 Capital Cube
02:48PM  ETFs with exposure to iBio, Inc. : October 25, 2016
Oct-24-16 09:10AM  iBio, Inc. :IBIO-US: Earnings Analysis: 2016 By the Numbers : October 24, 2016
Oct-13-16 04:07PM  IBIO, INC. Files SEC form 10-K, Annual Report
Sep-29-16 08:30AM  iBio Proprietary Technology Advances Neonatal Respiratory Distress Syndrome Drug Development for South African Biotech Company AzarGen Biotechnologies (Pty) Ltd Marketwired
Aug-15-16 08:30AM  Implications of Court Decision in Favor of iBio Against Fraunhofer Marketwired
Aug-04-16 08:31AM  iBio, Inc.'s Claims Against Fraunhofer Affirmed by Delaware Chancery Court Marketwired
Jul-05-16 08:31AM  iBio, Inc. Receives FDA Orphan Drug Designation for Fibrosis Product Candidate Marketwired -9.42%
Jun-29-16 08:31AM  iBio, Inc. Receives New Patent for Its Biotherapeutic Products for Treatment of Fibrosis Marketwired
Jun-07-16 08:31AM  Texas A&M University System and iBio Execute Joint Development Agreement for Plant-Produced Pharmaceuticals Marketwired
May-23-16 04:46PM  IBIO, INC. Files SEC form 10-Q, Quarterly Report
Apr-08-16 06:04AM  IBIO, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Financi
Apr-07-16 05:46PM  iBio, Inc. Holds Annual Meeting in College Station, Texas Marketwired
Mar-02-16 04:04PM  IBIO, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Feb-26-16 12:28PM  iBio, Inc. Earnings Analysis: Q2, 2016 By the Numbers
Feb-22-16 06:04AM  IBIO, INC. Files SEC form 10-Q, Quarterly Report
Feb-01-16 12:08PM  Largest Insiders' Trades of the Last Week
Jan-29-16 04:10PM  IBIO, INC. Files SEC form 8-K, Shareholder Director Nominations, Other Events
Jan-14-16 09:08AM  IBIO, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Re +21.78%
09:00AM  iBio Forms Joint Venture CMO for Large-Scale Pharmaceuticals Manufacturing in Green Plants and Accepts Additional Investment Marketwired
Jan-08-16 08:00AM  The Rosen Law Firm, P.A. Announces Proposed Class Action Settlement on Behalf of Purchasers of Common Stock of iBio, Inc. -- IBIO GlobeNewswire
Dec-16-15 10:52AM  iBio, Inc. Earnings Analysis: Q1, 2016 By the Numbers
Nov-30-15 08:31AM  iBio Continues Global Expansion of Intellectual Property Marketwired
Nov-19-15 08:31AM  Scientific Insights Into IBIO-CFB03 Presented at American College of Rheumatology Annual Meeting Marketwired
Nov-13-15 05:19PM  IBIO, INC. Files SEC form 10-Q, Quarterly Report
Oct-27-15 08:31AM  iBio European Protein Expression Patent Emerges From Opposition Period Marketwired
Oct-13-15 05:04PM  IBIO, INC. Files SEC form 10-K, Annual Report
Sep-30-15 08:31AM  New Chinese iBioModulator(TM) Patent Joins iBio Vaccine Portfolio Marketwired
Sep-21-15 08:31AM  iBio Anti-Fibrosis Portfolio Expanded to Include Orally Delivered Peptides Marketwired
Sep-10-15 09:00AM  iBio's Robert Erwin Interviewed by The Life Sciences Report Marketwired
Sep-09-15 08:31AM  iBio Fibrosis Therapeutics Program Receives NIH Grant Support Marketwired
Aug-11-15 08:31AM  iBio to Receive US Patent for Influenza Therapeutic Marketwired
Jun-18-15 02:31PM  3 Biotech Stocks Under $10 to Trade for Breakouts at TheStreet
Jun-08-15 08:31AM  Three Recent iBioLaunch(TM) Platform Achievements to Be Presented at PBVAB 2015 Conference in Lausanne, Switzerland Marketwired
May-17-15 08:11PM  10-Q for iBio, Inc. at Company Spotlight
May-15-15 04:31PM  IBIO, INC. Files SEC form 10-Q, Quarterly Report
May-04-15 11:17AM  Vaccine Improvement Patent Awarded to iBio at noodls
08:31AM  Vaccine Improvement Patent Awarded to iBio Marketwired
Apr-27-15 09:04AM  iBio Arranges Production of IBIO-CFB03 for Clinical Development with Caliber Biotherapeutics at noodls
iBio, Inc., a biotechnology company, focuses on developing and commercializing pharmaceutical product applications using its platform in the United States and internationally. Its lead therapeutic candidate is IBIO-CFB03 for the treatment of systemic scleroderma, idiopathic pulmonary fibrosis, and other fibrotic diseases. It is also developing vaccine candidates for third parties. The company has license and collaboration agreements with Caliber Biotherapeutics LLC and Fiocruz; and collaboration agreements with the A & M University System, AzarGen Biotechnologies (Pty) Ltd, Fraunhofer Center for Molecular Biotechnology, and Theoremdx, Inc. In addition, it offers a range of product and process development, analytical, and manufacturing services. iBio, Inc. is based in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Eastern Capital LTD10% OwnerNov 30Buy0.2012,000,0002,400,00045,744,000Dec 04 05:14 PM